Disclosure Plus

D.C.K. Investment to Launch Tender Offer for GABIA, Inc.

Shin Ha-yeon
2026-07-20 08:14:07
[Edaily Reporter Shin Ha-yeon ] Macquarie Korea Opportunities Private Investment Limited Partnership No. 6, managed by Macquarie Asset Management, acquired 9,805,505 shares (73.1% of the total issued shares) of Gavia, a KOSDAQ-listed company, through the special purpose company(SPC) DCK Investment, announced on the 20th that it will conduct a tender offer for 9,805,505 common shares (73.1% of the total issued shares) of KOSDAQ-listed company GABIA, Inc. at 48,000 won per share.
The tender offer period runs from the 20th through September 17, and the scheduled settlement date is September 21. The minimum intended purchase quantity is 3,267,629 shares (24.3%). If the number of shares tendered falls short of the minimum quantity, the tender offer will not proceed. If the number of shares tendered meets or exceeds the minimum quantity, all tendered shares will be purchased.
The tender offeror plans to voluntarily delist GABIA, Inc. through this tender offer and subsequently incorporate it as a wholly-owned subsidiary. Previously, the company also signed a share purchase agreement to acquire 3,270,248 shares (24.4%) held by CEO Kim Hong-guk, the largest shareholder, and two related parties, at 48,000 won per share.

Economy

Corporation

IT·Science

Economy

"Aftermath of the Jensen Huang Scandal… U.S. to Impose Strict Export Controls on China"

“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
2026-11-13 17:31:12

Corporation

HITEJINRO Enters the Soju-Beer Mix Cans Market… Remarks by Cho Woong-rae, Chairman of Shenyang Soju

“I hear that a major conglomerate is set to launch a soju-beer mix can—a blend of Terra Beer and Chamisul—in the soju-beer can market that we’ve worked so hard to pioneer.”This is a handwritten post t…
2026-11-13 19:38:55

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02